Coapt, LLC

Coapt, LLC has 1 AI-enabled medical device on the FDA list. The first decision was on May 24, 2019 and the most recent on May 24, 2019 (COMPLETE CONTROL System Gen2). Its most common review panel is Neurology (1 device).